Andrew C. Weiss
Contatto Relazioni con gli Investitori presso IDORSIA LTD
Posizioni attive di Andrew C. Weiss
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IDORSIA LTD | Contatto Relazioni con gli Investitori | 01/06/2017 | - |
| Public Communications Contact | 01/06/2017 | - |
Storia della carriera di Andrew C. Weiss
Precedenti posizioni note di Andrew C. Weiss
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACTELION | Contatto Relazioni con gli Investitori | 05/05/2014 | 01/01/2017 |
| Public Communications Contact | 05/05/2014 | 01/01/2017 | |
| Bank Sarasin & Cie AG (Broker) | Analyst-Equity | - | 01/05/2007 |
| Julius Baer Holding AG | Corporate Officer/Principal | 01/01/2000 | 01/01/2005 |
| Bank Vontobel AG (Research Firm) | Analyst-Equity | - | - |
Formazione di Andrew C. Weiss
| University of Zurich | Graduate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 7 |
Posizioni
| Analyst-Equity | 2 |
| Investor Relations Contact | 2 |
| Public Communications Contact | 2 |
Settori
| Finance | 4 |
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IDORSIA LTD | Health Technology |
| Aziende private | 4 |
|---|---|
| Bank Sarasin & Cie AG (Broker) | Finance |
| Bank Vontobel AG (Research Firm) | Finance |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
| Julius Baer Holding AG | Finance |
- Borsa valori
- Insiders
- Andrew C. Weiss
- Esperienza